London. 14 March 2014. Norgine Ventures today announced that, together with a number of Agendia’s existing shareholders, it has provided debt financing of €15 million to Agendia NV, with Norgine leading the syndicate. This investment recognises the growth prospects of Agendia, a molecular diagnostic company marketing a suite of breast and colon cancer tests. The […]
London. 10 January 2014. Norgine Ventures today announced that it has provided financing of €5 million to SuperSonic Imagine SA. The financing was realised in form of private bonds with warrants. Norgine Ventures’ investment will enable SuperSonic Imagine to accelerate further technological development and commercial expansion in the US and in Asia. Norgine Ventures is […]
London. 13 December 2013, 07:00 AM GMT. Norgine Ventures today announced that it has provided debt financing of £7.5 million to Stanmore Implants Worldwide Ltd. This funding recognises the potential of Stanmore Implants, a pioneer in the global limb salvage and preservation orthopaedic implants markets. Norgine Ventures is a business entity of Norgine, a well-established […]
London. 10 September 2013. Norgine Ventures today announced that it has provided debt financing of £2 million to Internis Pharmaceuticals. This funding recognises the potential of Internis, an exciting and innovative British start-up company. Norgine Ventures is a business entity of Norgine, a well-established independent pan-European pharmaceutical company. Norgine Ventures’ backing will enable Internis to […]
